European Archives - Page 48 of 1203 - European Medical Journal

Widespread Ignorance of Alcohol’s Cancer Risk

Despite alcohol being a leading preventable cause of cancer in the United States, public awareness of its cancer risk remains strikingly low, according to a new study.

Critical Management of Neurocysticercosis with Hydrocephalus

Neurocysticercosis, a parasitic brain infection caused by the larvae of Taenia solium that leads to cysts in the central nervous system…

Minimally Invasive Treatment for Benign Prostatic Hyperplasia

Importantly, 30% mean reductions in prostate volume were sustained up to 18 months post-procedure.

Sun Pharma appoints Richard Ascroft as North American CEO

Ascroft brings more than 30 years of industry experience, including senior roles at Takeda Pharmaceuticals.

Can Microbiome-Guided Therapy Improve Cystic Fibrosis Outcomes?

A new international trial has investigated the safety and efficacy of tailoring antibiotic treatment for cystic fibrosis exacerbations based on sputum microbiome analysis.

Combined Therapy for Allergic Rhinitis Shows Superior Results

The combination therapy demonstrated a significantly higher response rate (98.28%) compared to loratadine alone (87.93%).

Mitigating the Treatment Gap in Drug-Resistant Epilepsy

For this article, EMJ conducted an interview with Ahmed Abdelmoity, Professor and Director, Division of Neurology, Children’s Mercy…

EMJ Neurology 13 [Supplement 7] 2025

Interview article with Prof. Abdelmoity, discussing the current treatment landscape for patients with drug-resistant epilepsy (DRE)…

New Technique Improves Recovery After Liver Surgery

A recent prospective study explored the effectiveness of using indocyanine green to improve intraoperative detection of bile leakage.

Torn agreement

US withdraws funding from Gavi, the Vaccine Alliance

The US plans to stop its financial contributions to Gavi, the Vaccine Alliance, marking an end to an over 20-year partnership.